If you want to cancel your application, please call us immediately. Once a loan is funded, you have a limited time frame to cancel your application, depending on your loan type.
If you decide to cancel, make sure you keep all the money in your account. We'll try to withdraw it within 5–7 business days.
Topics in this article:
- How to cancel a personal loan or line-of-credit application
- How to cancel an auto-refinance application
- How to cancel a Celink Patient Solutions loan application
How to cancel a personal loan or line-of-credit application
For personal loans and lines of credit, call us at 844-557-2551, Monday through Friday from 5 am – 5 pm Pacific Time. You’ll need to call us within 5 calendar days of when the loan was funded to cancel.
If you want to cancel a balance transfer loan, you’ll be responsible for having the funds in your account within 30 days from the day your loan is issued. We can't retrieve funds from your creditors, so you may need to contact them to collect those funds. We’ll try withdrawing the full amount from your account, including the funds sent to your creditors, as soon as you let us know it’s available. If the full amount hasn’t been retrieved after 30 days, you’ll be responsible for repaying the loan, any fees, and interest. To find out more, review the Borrower Agreement.
How to cancel an auto refinance loan application
For auto refinance loans, call us at 888-845-0010, Monday through Friday from 6 am – 5 pm Pacific Time. If we've already sent funds to your previous lender, you'll have 10 calendar days from the day you call us to return the funds.
How to cancel a Celink Patient Solutions loan application
For Celink Patient Solutions loans, call us at 800-630-1663, Monday through Friday from 6 am – 5 pm Pacific Time.
You must refund the full loan amount within 30 days of funding to have us waive your interest. Partial refunds or refunds after 30 days may be subject to an interest payment. Please note that refunds are only allowed if no services have already been performed.
Comments
0 comments
Article is closed for comments.